Lyka Labs Announces Quarter End Results and Approves Divestment of Subsidiary Stake
Lyka Labs Limited has announced the unaudited financial results for the first quarter ended June 30, 2026, both on a standalone and consolidated basis. The company's Board of Directors approved these results, alongside the strategic decision to divest its entire equity stake in Lyka BDR International Limited.The management noted that Lyka BDR International Limited is not a material subsidiary of the company.
Standalone Financial Performance Highlights
The Unaudited Financial Results for the quarter ended June 30, 2026, are available for review. The company operates in one business segment: Pharmaceuticals.Key financial details from the standalone results for the first quarter ending June 30, 2026 (in lakhs) are presented below:
| Particulars | Quarter Ended 30th Jun, 2026 (Unaudited) | Quarter Ended 31st Mar, 2026 (Unaudited) | Quarter Ended 30th Jun, 2025 (Unaudited) | Year Ended 31st Mar, 2026 (Audited) |
|---|---|---|---|---|
| Revenue from Operations | 4230.94 | 2803.07 | 2917.64 | 12090.53 |
| Other Income | 41.85 | 50.98 | 77.34 | 397.44 |
| Total Income | 4272.79 | 2854.04 | 2994.98 | 12487.96 |
| Cost of Materials Consumed | 1120.41 | 742.58 | 804.94 | 3177.43 |
| Purchase of Stock in trade | 750.15 | 499.88 | 224.86 | 1479.99 |
| Change in inventories | (225.72) | (139.66) | 15.97 | (107.94) |
| Employee benefits expense | 1147.61 | 1287.29 | 898.24 | 4160.22 |
| Finance Costs | 100.82 | 87.33 | 85.14 | 332.67 |
| Depreciation and amortisation expense | 200.96 | 204.39 | 211.18 | 845.98 |
| Other expenses | 979.21 | 861.23 | 637.91 | 3621.71 |
| Total Expenses | 4073.44 | 3543.04 | 2878.24 | 13510.05 |
| Profit / (Loss) before Taxes | 199.35 | (688.99) | 116.74 | (1022.09) |
| Net Profit / (Loss) after Tax | 210.03 | (2977.21) | 81.07 | (3228.84) |
Divestment of Lyka BDR International Limited
The Board of Directors has approved the proposal to divest the entire equity stake in its subsidiary, Lyka BDR International Limited. The company's Audit Committee has been delegated authority to complete the necessary steps for this divestment.Regarding the status of Lyka BDR International Limited during the last financial year (ending March 31, 2026), the entity contributed INR 1055.48 lakhs in Total Income and had a Net worth of (INR 449.17) lakhs.
Consolidated Financial Overview
The Unaudited Consolidated Financial Results for the quarter ended June 30, 2026, reflecting both Lyka Labs Limited and its subsidiary, Lyka BDR International Limited, are also available. The statutory auditors issued an unqualified conclusion on these consolidated financials.Consolidated results highlight a Total Income of INR 4,272.79 lakhs for the quarter ended June 30, 2026 (unaudited), compared to INR 13,194.24 lakhs in the year ended March 31, 2026 (audited).
A summary of the Consolidated Unaudited Financial Results is as follows:
| Particulars | Quarter Ended 30th Jun, 2026 | Quarter Ended 31st Mar, 2026 | Quarter Ended 30th Jun, 2025 | Year Ended 31st Mar, 2026 |
|---|---|---|---|---|
| Total Income | 4,272.79 | 2,864.19 | 3,365.63 | 13,194.24 |
| Total Expenses | 4,077.99 | 3,722.81 | 3,230.46 | 14,372.18 |
| Net Profit / (Loss) after Tax | 204.66 | (806.63) | 99.62 | (1,043.56) |
LYKALABS Stock Price Movement
Shares are edging higher to ₹67.2 as of 12:38 PM, climbing by ₹0.46 or 0.69% in live trading. The movement occurs amidst moderate activity, with a recorded volume of 2,103 shares traded for the security.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: